T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Wabtec
WAB
$50.1B
| $577M | 0.07% |
10,015,334
-1,585,315
| -14% | -$89.8M |
|
277
DraftKings
DKNG
$12.5B
| $573M | 0.07% |
+17,218,336
| New | +$476M |
|
278
BWX Technologies
BWXT
$15.6B
| $571M | 0.07% |
10,076,143
-2,757,263
| -21% | -$154M |
|
279
Entergy
ETR
$49.9B
| $568M | 0.07% |
12,104,220
+1,547,040
| +15% | +$75.1M |
|
280
Molina Healthcare
MOH
$10.8B
| $563M | 0.07% |
3,162,313
-349,111
| -10% | -$59.5M |
|
281
KKR & Co
KKR
$101B
| $561M | 0.07% |
18,159,306
-284,605
| -2% | -$7.65M |
|
282
Halliburton
HAL
$27.4B
| $555M | 0.07% |
42,726,516
+24,057,887
| +129% | +$259M |
|
283
MGM Resorts International
MGM
$11.1B
| $551M | 0.07% |
32,769,062
-4,674,487
| -12% | -$75.5M |
|
284
Acadia Pharmaceuticals
ACAD
$4.94B
| $550M | 0.07% |
11,341,786
-486,119
| -4% | -$23.3M |
|
285
Altria Group
MO
$109B
| $536M | 0.07% |
13,646,503
+4,325,725
| +46% | +$169M |
|
|
INFO
286
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $533M | 0.07% |
7,053,397
-12,962
| -0.2% | -$882K |
|
287
XP
XP
$8.11B
| $529M | 0.07% |
12,600,383
-781,464
| -6% | -$24M |
|
288
Baidu
BIDU
$35.3B
| $529M | 0.07% |
4,414,974
+2,253,284
| +104% | +$241M |
|
|
KL
289
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $526M | 0.07% |
12,775,978
-155,581
| -1% | -$6.01M |
|
|
SBNY
290
DELISTED
Signature Bank
SBNY
| $525M | 0.07% |
4,914,536
+154,162
| +3% | +$15.2M |
|
291
Rollins
ROL
$17.5B
| $523M | 0.07% |
18,502,028
-1,903,299
| -9% | -$50.9M |
|
292
Rayonier
RYN
$6.5B
| $513M | 0.06% |
22,822,408
+96,931
| +0.4% | +$2.11M |
|
293
FirstService
FSV
$6.14B
| $511M | 0.06% |
5,067,837
-13,632
| -0.3% | -$1.21M |
|
294
Bristol-Myers Squibb
BMY
$133B
| $508M | 0.06% |
8,643,465
-1,051,375
| -11% | -$62.9M |
|
295
Ionis Pharmaceuticals
IONS
$9.26B
| $508M | 0.06% |
8,611,362
+4,848,917
| +129% | +$270M |
|
296
Credicorp
BAP
$29.9B
| $507M | 0.06% |
3,791,633
+66,903
| +2% | +$9.53M |
|
297
Williams Companies
WMB
$90B
| $501M | 0.06% |
26,334,901
+21,323,489
| +425% | +$397M |
|
298
ICU Medical
ICUI
$4.55B
| $492M | 0.06% |
2,667,100
-7,131
| -0.3% | -$1.42M |
|
299
Planet Fitness
PLNT
$3.65B
| $488M | 0.06% |
8,060,267
+7,061,416
| +707% | +$424M |
|
300
Envista
NVST
$4.49B
| $485M | 0.06% |
22,976,476
-4,222,133
| -16% | -$79.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.